Strs Ohio Bridge Bio Pharma, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Strs Ohio holds 6,900 shares of BBIO stock, worth $166,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,900

Previous 6,900 -0.0%

Holding current value

$166,359

Previous $174,000 0.57%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$23.0 - $31.04 $50,600 - $68,288	2,200 Added 46.81%	6,900 $174,000
Q1 2024 May 13, 2024	SELL	$27.35 - $40.45 $117,605 - $173,935	-4,300 Reduced 47.78%	4,700 $145,000
Q4 2023 Jan 30, 2024	BUY	$24.02 - $43.89 $50,442 - $92,169	2,100 Added 30.43%	9,000 $363,000
Q3 2023 Oct 26, 2023	BUY	$16.89 - $35.01 $116,541 - $241,569	6,900 New	6,900 $181,000
Q1 2022 Apr 21, 2022	SELL	$7.34 - $17.16 $53,582 - $125,268	-7,300 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$11.38 - $53.41 $40,968 - $192,276	-3,600 Reduced 33.03%	7,300 $121,000
Q3 2021 Oct 22, 2021	SELL	$46.87 - $64.24 $121,862 - $167,024	-2,600 Reduced 19.26%	10,900 $510,000
Q2 2021 Jul 26, 2021	SELL	$46.47 - $63.93 $37,176 - $51,144	-800 Reduced 5.59%	13,500 $822,000
Q1 2021 Apr 23, 2021	BUY	$55.47 - $72.35 $355,008 - $463,039	6,400 Added 81.01%	14,300 $880,000
Q4 2020 Jan 25, 2021	BUY	$38.38 - $71.11 $99,788 - $184,886	2,600 Added 49.06%	7,900 $561,000
Q3 2020 Dec 14, 2020	BUY	$27.2 - $42.19 $13,600 - $21,095	500 Added 10.42%	5,300 $198,000
Q2 2020 Jul 23, 2020	BUY	$22.22 - $35.69 $106,656 - $171,312	4,800 New	4,800 $156,000
Q1 2020 Apr 23, 2020	SELL	$16.11 - $36.23 $95,049 - $213,756	-5,900 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$20.13 - $32.38 $118,767 - $191,042	5,900 New	5,900 $126,000

Others Institutions Holding BBIO

# of Institutions

288

Shares Held

171M

Call Options Held

8.38M

Put Options Held

2.27M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.57B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account